Y-mAbs Therapeutics, Inc.
$1.7M 159 recipients
Compare payment profiles
CMS Open Payments · Program Year 2024
Dompe US, Inc.
Dompe US, Inc. reported $1,730,522.98 across General Payments, Research, and Ownership to 11,308 physicians and teaching hospitals across 11,319 transactions.
- $1.7M Above-median payer
- All-tracks total
- 11,319 Top 10% volume
- Transactions
- 11,308 Top 10% reach
- Recipients
- +$213.3K
- General Payments vs PY2023
Dompe US, Inc. reported $1,730,522.98 across all CMS Open Payments tracks (General + Research + Ownership) to 11,308 physicians and teaching hospitals in Program Year 2024 - ranking #484 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $1,253,071.89, averaging $153.04 per recipient.
How Dompe US, Inc.'s $1.7M all-tracks total breaks down
Dompe US, Inc.'s payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
C
76/100
Total payments
F
26/100
Transaction volume
A
92/100
Physician reach
A
96/100
Payment type diversity
A
90/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer dompe-us-inc Dompe US, Inc.
$1.7M · #484/1,925 · 0.0% industry · PY2024
- TOT $1.7M
- RANK #484
- SHARE 0.0%
- TXN 11,319
- RCP 11,308
- CAT 7
- GEN $1.3M
- ΔGEN +$213.3K
- TOP1 5.6%
- PY 2024
Volume peers
Nearest volume peer: Y-mAbs Therapeutics, Inc. ($1.7M)
Dompe US, Inc. sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
Dompe US, Inc.'s CMS-reported General Payments increased by $213.3K (+20.5%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2022: DOMPE US, INC.PY2023: DOMPE US, INC.PY2024: Dompe US, Inc.. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $1,039,788.77
- PY2024
- $1,253,071.89
What the Data Shows for Dompe US, Inc.
Three separate CMS disclosure tracks feed the all-tracks total above - General, Research, and Ownership/Investment - each reported under its own rules and combined here for one comparable figure. For Dompe US, Inc., that total blends General Payments (day-to-day consulting, meals, travel and speaking fees, shown separately above) with Research and Ownership/Investment interest records, each governed by its own CMS reporting rules. CMS releases each Program Year roughly 12 months after it ends; the methodology page covers the full standardization basis.
The 7-category breakdown below covers general payments only (see our methodology for how research and ownership payments are reported separately). The largest general-payment category is "Compensation for Faculty or Speaker (Medical Education)" at $463.0K, accounting for 36.9% of this company's General Payments and 178 transactions.
General Payment Breakdown by Type
Dompe US, Inc. made 7 types of general payments. "Compensation for Faculty or Speaker (Medical Education)" is the largest category at $463.0K, 36.9% of General Payments.
Dompe US, Inc. reports 7 general-payment categories - the top three are Compensation for Faculty or Speaker (Medical Education) (36.9%), Food and Beverage (35.6%), and Consulting Fee (15.3%). The remaining 4 categories make up 12.1% of this company's reported general-payment total. That multi-category mix is the kind of profile single-category reporters cannot show.
How Dompe US, Inc. divides its payments
Top payment categories by total reported dollar volume
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Compensation for Faculty or Speaker (Medical Education) | $463.0K | 178 | 36.9% |
| Food and Beverage | $446.3K | 10,589 | 35.6% |
| Consulting Fee | $192.0K | 60 | 15.3% |
| Travel and Lodging | $114.8K | 421 | 9.2% |
| Grant | $20.0K | 2 | 1.6% |
| Charitable Contribution | $15.0K | 1 | 1.2% |
| Education | $2.0K | 57 | 0.2% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $201,670.24 (16.1%) of $1,253,071.89 in this company's General Payments records across 7,050 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Dompe US, Inc.
The five named recipients with the highest reported General Payments from this company
- 1
John Affeldt
$70,250.84 across 115 reported transactions
- 2
Nishi Shah
$49,186.92 across 113 reported transactions
- 3
Timothy Poirier
$28,256.39 across 68 reported transactions
- 4
Pedram Hamrah
$27,643.18 across 8 reported transactions
- 5
John Sheppard
$26,332.91 across 27 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
Dompe US, Inc. ranks #484 of 1,925 by total payments (top 25% by spend) but spreads that money notably more broadly than its spend rank alone would suggest -- #1,677 of 1,838 by HHI (bottom 9% least concentrated), a wider distribution than most similarly sized payers.
View all 12 companies in this HHI neighborhood as a list
- Glaukos Corporation : $3.6M total payments, HHI 112
- Southern Anesthesia & Surgical, Inc (dba Ace Southern) : $3.8K total payments, HHI 112
- Actelion Pharmaceuticals US, Inc. : $5.0M total payments, HHI 112
- Array Biopharma Inc : $400.2K total payments, HHI 112
- Travere Therapeutics, Inc. : $2.0M total payments, HHI 112
- Avion Pharmaceuticals : $3.5K total payments, HHI 112
- Dompe US, Inc. (this company) : $1.3M total payments, HHI 111
- ADC Therapeutics America, Inc. : $1.1M total payments, HHI 111
- Kyowa Kirin, Inc. : $2.5M total payments, HHI 111
- Xeris Pharmaceuticals, Inc. : $1.2M total payments, HHI 110
- Mallinckrodt Hospital Products Inc. : $7.6M total payments, HHI 109
- Lexicon Pharmaceuticals, Inc. : $2.5M total payments, HHI 108
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Dompe US, Inc.'s, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Dompe US, Inc..
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Dompe US, Inc..
Showing 6 of 1,924 companies with CMS-reported payment data.
Pharmacosmos Therapeutics Inc.
$1.7M 7,020 recipients
Compare payment profiles
Esperion Therapeutics, Inc.
$1.7M 27,251 recipients
Compare payment profiles
Radiometer America, Inc
$1.7M 84 recipients
Compare payment profiles
bioMerieux Inc
$1.7M 600 recipients
Compare payment profiles
Medivation LLC.
$1.7M 3 recipients
Compare payment profiles
Put this to use
Dompe US, Inc. ranks #484 of 1,925 by all-tracks total payments, led by "Compensation for Faculty or Speaker (Medical Education)".
- See where Dompe US, Inc. sits among every top spender on the full leaderboard. Top 100 by total payments
- Compare "Compensation for Faculty or Speaker (Medical Education)" spend across every manufacturer, not just Dompe US, Inc.. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.